Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Most Americans concerned about rising drugs costs amid COVID-19, Gallup says

By Sean Whooley | June 22, 2020

coronavirus COVID-19

[Photo by Fusion Medical Animation on Unsplash]

A new study by West Health and Gallup revealed that Americans are concerned with potential negative developments resulting from the COVID-19 pandemic.

Nearly 90% of the 1,016 U.S. adults surveyed between May 11, 2020, and May 22, 2020, said they are “very” (55%) or “somewhat” (33%) concerned that the pharmaceutical industry will leverage the ongoing pandemic to raise drug prices. According to a news release, Democrats (66%) were more likely to say they are concerned than independents (52%) and Republicans (49%).

Other concerns raised include, to a lesser extent, rising health insurance premiums and the general cost of care, with 79% of those surveyed saying they are very or somewhat concerned about their premiums. Additionally, 84% said they are very or somewhat concerned about the cost of care generally rising and 41% are very concerned about each.

Nearly half (48%) of women polled were very concerned about the general cost of care rising, while 33% of men were in the same bracket. Additionally, 50% of non-whites are very concerned, compared to 36% of whites. About 88% of those polled support direct negotiations by the federal government with a drug manufacturer on the price of treatment for the disease itself.

Gallup and West Health concluded that, with 14% of Americans refusing to seek treatment for COVID-19 symptoms because of the cost of care, leaders may consider policy decisions designed to curtail the possibilities of raised costs, easing the fears of the public.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
Eli Lilly Huntsville Alabama Facility rendering (1)
Eli Lilly to build new $6B API manufacturing facility in Alabama
Thermo Fisher Scientific
Thermo Fisher expands investment in Asia bioprocessing for biopharma production
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE